Delivery Order SPE2DB24D2205-SPE2DB25FECSC
Award Date
5/21/25
Potential Completion Date
5/22/25
Potential Value
$7.4K
Federal Agency
Defense Logistics Agency
Awardee
Amerisourcebergen Drug Corp
Ultimate Awardee
Not listed
NAICS Category
424210 - Drugs and Druggists' Sundries Merchant Wholesalers
PSC Category
6505 - Drugs And Biologicals
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp Corporate Office Division, a major pharmaceutical distributor. The contract is for the supply of the ROTARIX vaccine oral syringe, 1.5 milliliters, at a ceiling value of $5,231.01. The contract is a firm fixed price, delivery order type and has a period of performance through September 6, 2024. This order is not associated with a set-aside program. AmerisourceBergen holds an...
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider, for the delivery of the ROTARIX vaccine oral syringes (1.5 mL). The firm-fixed-price delivery order, valued at $10,682.65, has a period of performance through February 2025. AmerisourceBergen holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at $999,999,999 and running...
This is a firm fixed-price delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, for the supply of Rotarix vaccine oral syringes. The contract has a ceiling value of $3,458.03 and a period of performance through April 30, 2025. AmerisourceBergen holds a substantial Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, valued at $999,999,999.00, which serves as a comprehensive global pharmaceutical support...
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $5,168.31 firm fixed-price delivery order is for the supply of 4,568,239,230 units of the ROTARIX vaccine oral syringe, 1.5 ml. The contract has a period of performance through May 14, 2025 and is not set aside for any particular business category. AmerisourceBergen Drug Corp holds a significant $999,999,999.00...
This is a firm fixed-price delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, for the supply of the ROTARIX vaccine oral syringe 1.5 mL. The contract has a ceiling value of $4,429.98 and a performance period extending through May 5, 2025. This delivery order is not designated as a set-aside contract, indicating open competition. AmerisourceBergen Drug Corp holds a significant Indefinite Delivery Contract (IDC) with the...
This is a federal contract award from the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of the ROTARIX vaccine oral syringes 1.5ML, with a ceiling value of $3,290.49 and a completion date of March 19, 2025. The contract is a delivery order under a larger Indefinite Delivery Contract (IDC) between Amerisourcebergen and the DLA Troop Support Medical, valued at $999,999,999 and...
This is a federal contract award from the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, with a ceiling value of $12,870.81, is for the delivery of the ROTARIX vaccine oral syringe 1.5ML. It is a firm fixed-price delivery order contract with a period of performance through March 6, 2025. The contract is not designated as a set-aside. AmerisourceBergen holds a significant Indefinite Delivery...
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the supply of 4,567,926,398 units of the ROTARIX vaccine oral syringe, 1.5 ml in size. The contract is a firm fixed-price, non-set-aside award with a ceiling value of $7,606.35 and a performance period through April 16, 2025. AmerisourceBergen Drug Corp also holds a significant Indefinite Delivery...
This federal contract award, valued at $5,140.28, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of Rotarix vaccine oral syringes (1.5 mL) and has an ultimate completion date of April 23, 2025. The contract is a firm fixed-price delivery order with no set-aside designation, indicating open competition. Amerisourcebergen Drug Corp holds a significant...
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $2,272.35 firm fixed-price delivery order is for the supply of ROTARIX vaccine oral syringes, 1.5 mL, with an ultimate completion date of December 23, 2024. The contract does not have a set-aside designation, indicating open competition. AmerisourceBergen holds a $999,999,999 Indefinite Delivery Contract (IDC)...